Browse our anti-CD9 (CD9) Antibodies

Mouse (Murine) CD9 interaction partners

1. The Cd9(-/-) and Cd9(-/-) Cd81(-/-) deletions are associated with a decreased microvilli density on the MII oocyte surface. Microvilli thickness is significantly increased whatever the deleted tetraspanin gene be. Only Cd9 deletion clearly disturbs the vesicular traffic, increasing the number of clathrin and exosome vesicles.

2. CD9 regulates the T cell-stimulatory capacity of granulocyte-macrophage colony-stimulating factor (GM-CSF (show CSF2 Antibodies))-dependent bone marrow-derived Dendritic Cells (BMDCs), without affecting antigen presentation by fms-like tyrosine kinase 3 ligand (Flt3L)-dependent BMDCs.

3. DPP4 (show DPP4 Antibodies):CD9:TTSP (show TMPRSS11E Antibodies) as the protein complexes are necessary for early efficient MERS-coronavirus entry.

4. Our results indicate that the suppression of cartilage degradation in CD9(-/-) could be in part related to an increase in the expression of the two main cartilage extracellular matrix proteins aggrecan (show ACAN Antibodies) and type II collagen (show COL2A1 Antibodies).

5. Tetraspanin CD9 and ectonucleotidase CD73 identify an osteochondroprogenitor population with elevated osteogenic properties.

6. Data indicate that anti-inflammatory effects of statins are CD9-dependent.

7. study demonstrates ablation of Cd9 had no detectable effect on de novo primary proatate tumour onset, but did significantly increase metastasis to the liver but not the lungs

8. In vitro myotubes lacking CD9P-1 (show PTGFRN Antibodies) or both CD9 and CD81 (show CD81 Antibodies) fuse with a higher frequency than normal myotubes

9. chemotaxis toward antigen is controlled in mast cells by a cross-talk among FcepsilonRI (show FCER1A Antibodies), tetraspanin CD9, transmembrane adaptor proteins NTAL (show LAT2 Antibodies) and LAT (show LAT Antibodies), and cytoskeleton-regulatory proteins of the ERM (show ETV5 Antibodies) family

10. tetraspanin CD9 modulates molecular organization of integrins in lymphatic endothelial cells, thereby supporting several functions required for lymphangiogenesis

Human CD9 interaction partners

1. CD9 expression predicts some clinical characteristics and indicates an unfavorable prognosis in acute lymphoblastic leukemia patients.

2. CD9-CD81 (show CD81 Antibodies) blockage reduces exosome-mediated HIV-1 entry.

3. Exosomal markers CD63 (show CD63 Antibodies) and CD9 are elevated in pancreatic tumor tissues.

4. CD9 expression could be a biomarker for poor prognosis in invasive breast carcinoma

5. CD9 stabilizes gp130 (show IL6ST Antibodies) by blocking its ubiquitin-dependent lysosomal degradation to promote the IL6 (show IL6 Antibodies)-gp130 (show IL6ST Antibodies)-bone marrow X-linked non-receptor tyrosine kinase (show TNK1 Antibodies)-STAT3 (show STAT3 Antibodies) signaling for maintaining GSC (show GSC Antibodies) selfrenewal and tumorigenic capacity.

6. CD9 was highly expressed on extravillous trophoblast (EVT) at the boundary region of EVT invasion and intravascular EVT. CD9 expression on Swan71 cells was reduced under hypoxic conditions, while its expression was increased by co-culture with HUVEC. CD9 could attenuate EVT invasion under the influence of an oxygen environment and maternal endothelial cells, proposing CD9 as a potential regulator of human placentation.

7. As for 18Lin(-), CD34 (show CD34 Antibodies)(-) HSCs are characterized by low expression of the tetraspanin CD9, which promotes homing, and high expression of the peptidase CD26 (show DPP4 Antibodies), which inhibits homing.

8. The findings suggest that, in contrast with previous models, the ligand-binding site of integrin alphaVbeta3 (show ITGAV Antibodies), binds to the constant region (helices A and B) of the EC2 (show TCF15 Antibodies) domain of CD9, CD81 (show CD81 Antibodies), and CD151 (show CD151 Antibodies) antigens.

9. Data suggest that CD9 should be further evaluated as a target for glioblastoma treatment.

10. Collectively, using tetraspanin CD9 in tandem with E-cadherin (show CDH1 Antibodies) as a biomarker in renal cell carcinoma (show MOK Antibodies) will help to not only distinguish between types, but also predict the metastatic potential of RCC (show XRCC1 Antibodies).

Cow (Bovine) CD9 interaction partners

1. Tests showed that the vitrification/warming procedures significantly decreased CD9 expression at the mRNA and protein levels, and changed the CD9 distribution pattern in bovine oocytes.

2. Immortalized microvascular endothelial cells of the bovine retina express members of the tetraspanin family of which CD9 was demonstrated to have a function in migration and adhesion of these cells.

3. CD9 present on bovine matured oocytes is involved in sperm-oocyte interaction during fertilization.

Pig (Porcine) CD9 interaction partners

1. analysis of tetraspanin CD9 distribution in normal porcine tissues